AFAP1 and non-small cell lung carcinoma: In Huang’s study on non-small cell lung cancer (27), the results showed that AFAP1-AS1 up-regulated RRM2 by inhibiting miR-139-5p expression, which in turn promoted the proliferation and chemotherapy tolerance of NSCLC cells.